Pregabalin Completed Phase 2 Trials for Diabetic Peripheral Neuropathic Pain (DPN) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00838799Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain
NCT01314222Diabetic Peripheral Neuropathic Pain (DPNP)